2.2 High-Alert Medications, Parenteral Therapy & Adverse Drug Reactions

High-Alert Medications

The Institute for Safe Medication Practices (ISMP) defines high-alert medications as drugs that bear a heightened risk of causing significant patient harm when they are used in error. While mistakes may or may not be more common with these drugs, the consequences of an error are far more devastating.

Common High-Alert Medications

Nurses must exercise extreme vigilance when handling the following classes of medications:

• Anticoagulants (e.g., Heparin, Warfarin): Errors can lead to severe hemorrhage or fatal thrombotic events.
• Insulins: Incorrect dosing can cause life-threatening hypoglycemia or profound diabetic ketoacidosis.
• Opioids and Narcotics: Overdoses can cause fatal respiratory depression.
• Electrolytes (Concentrated): Intravenous potassium chloride must never be administered via IV push. Rapid infusion can cause lethal cardiac dysrhythmias and immediate cardiac arrest.
• Inotropic Medications (e.g., Digoxin, Epinephrine): These have a narrow therapeutic index and potent cardiovascular effects.

Protocols for High-Alert Medications

To mitigate risks, hospitals employ strict protocols for high-alert medications. The most critical nursing intervention is the independent double-check. This requires two licensed nurses to separately verify the medication order, calculate the dose independently, and confirm the drug, concentration, and patient identity before administration.

Antidotes and Reversal Agents

Familiarity with specific antidotes is frequently tested on nursing board exams:

---

Monitoring Anticoagulant Therapy

Anticoagulants are frequently administered in the clinical setting, demanding rigorous laboratory monitoring.

• Heparin (Unfractionated): Administered IV or Subcutaneously. Its therapeutic effect is evaluated using the activated partial thromboplastin time (aPTT). A normal baseline aPTT is typically 25-35 seconds; the therapeutic goal is usually 1.5 to 2.5 times the baseline (e.g., 50-70 seconds).
• Warfarin: Administered orally. Efficacy is monitored using the Prothrombin Time (PT) and International Normalized Ratio (INR). A normal INR for an individual not on anticoagulants is roughly 1.0. For most patients on warfarin therapy (e.g., for atrial fibrillation or DVT prophylaxis), the therapeutic INR target is 2.0 to 3.0.

---

Parenteral Therapy and Intravenous Complications

Parenteral therapy bypasses the gastrointestinal tract, delivering fluids, nutrients, and medications directly into the vascular system. While highly effective, it introduces significant risks. The nurse must routinely assess IV sites and promptly identify complications.

Common IV Complications

1. Infiltration: Occurs when a non-vesicant IV fluid leaks into the surrounding subcutaneous tissue.
   • Signs/Symptoms: Swelling, coolness to the touch, pallor at the site, and a sluggish flow rate.
   • Intervention: Stop the infusion immediately, remove the IV catheter, elevate the extremity, and apply warm or cold compresses according to facility policy.
2. Phlebitis: Inflammation of the vein, often caused by mechanical trauma from the catheter or chemical irritation from medications.
   • Signs/Symptoms: Erythema (redness), warmth, pain or tenderness along the course of the vein, and a palpable cord.
   • Intervention: Stop the infusion, remove the catheter, and apply a warm, moist compress.
3. Extravasation: The leakage of a vesicant drug (a medication capable of causing severe tissue damage and necrosis, such as chemotherapy or vasopressors) into the tissue.
   • Intervention: Stop the infusion immediately. Leave the catheter in place temporarily to attempt aspiration of the drug and to administer a specific antidote directly into the tissue if one exists, then remove the catheter.
4. Air Embolism: The entry of air into the vascular system, potentially traveling to the right ventricle and pulmonary circulation.
   • Signs/Symptoms: Sudden onset of dyspnea, chest pain, cyanosis, tachycardia, and hypotension.
   • Intervention: Clamp the tubing immediately, place the patient on their left side in the Trendelenburg position (this traps air in the right atrium, preventing it from entering the pulmonary artery), administer 100% oxygen, and notify the physician.

---

Adverse Drug Reactions and Anaphylaxis

Nurses must differentiate between expected side effects and dangerous adverse drug reactions.

• Side Effects: Predictable, often unavoidable secondary effects at therapeutic doses (e.g., nausea with oral antibiotics, dry mouth with anticholinergics).
• Adverse Drug Reactions (ADRs): Unintended, undesirable, and often unpredictable severe responses to a medication. These require discontinuation of the drug and often medical intervention.

Anaphylaxis

Anaphylaxis is the most severe and life-threatening form of an allergic reaction. It involves a systemic, immunoglobulin E (IgE)-mediated hypersensitivity response resulting in massive vasodilation and increased capillary permeability.

• Clinical Presentation: Symptoms develop rapidly and include profound hypotension, tachycardia, bronchospasm, wheezing, stridor, urticaria (hives), and angioedema (swelling of the lips, tongue, and airway).
• Immediate Nursing Interventions:
  1. Stop the causative agent: If administering an IV medication or blood product, stop the infusion immediately but maintain IV access with normal saline.
  2. Assess Airway and Breathing: Ensure a patent airway and administer high-flow oxygen.
  3. Administer Epinephrine: Intramuscular (IM) epinephrine is the first-line and most critical medication. It stimulates alpha-1 receptors (causing vasoconstriction to raise blood pressure) and beta-2 receptors (causing bronchodilation to relieve airway obstruction).
  4. Positioning: Elevate the lower extremities to improve venous return and blood pressure.
  5. Adjunctive Therapies: Prepare to administer antihistamines (e.g., diphenhydramine), corticosteroids, and IV fluids as prescribed.

Clinical Nursing Considerations

• Always obtain a thorough allergy history, including the specific nature of the reaction (e.g., "Did you have a rash, or did you stop breathing?").
• Observe patients closely for at least 15-30 minutes after initiating a new medication, particularly IV antibiotics like penicillins and cephalosporins, which have a higher incidence of cross-reactivity and allergic responses.